Sergio Duron

Outlook Mobile Friendly WordPress.org Google Font API Gravity Forms reCAPTCHA Google Tag Manager Typekit Remote

biotech antibody drug conjugates covalent biologics covalent protein drugs oncology biotechnology research protein therapeutics oncology treatments synthetic biology war-lock platform protein engineering therapeutic targeting covalent binding biologic drugs drug discovery improved efficacy safety profiles target modulation unbound pharmaceuticals latent proteins high specificity aminos acid technology first-in-class therapies clinical development cancer therapeutics monoclonal antibodies antibody-drug conjugates medicinal chemistry biopharmaceutical research precision medicine biologic safety drug formulation systemic exposure unbinding mechanisms therapeutic index novel therapeutics lead candidates high throughput assays clinical trials biotech innovation pharmaceutical development therapeutic delivery systems latency mechanism disease-target biology natural amino acid substitutes in vivo applications immunotherapeutics biologics engineering molecular programming clinical biomarkers targeted therapies next-generation therapeutics novel protein agents hospital & health care biotechnology health care health wellness & fitness